08:00 , Nov 16, 2015 |  BC Week In Review  |  Financial News

BioRestorative Therapies amends best efforts offering

BioRestorative Therapies Inc. (OTCQB:BRTX), Melville, N.Y.   Business: Endocrine/Metabolic, Cardiovascular, Gene/Cell therapy   Date announced: 2015-11-05   Type: Best efforts offering   To be raised: Up to $4 million   Shares: 842,106   Price prior:...
08:00 , Nov 2, 2015 |  BC Week In Review  |  Financial News

BioRestorative Therapies amends follow-on

BioRestorative Therapies Inc. (OTCQB:BRTX), Melville, N.Y.   Business: Endocrine/Metabolic, Cardiovascular, Gene/Cell therapy   Date announced: 2015-10-27   Type: Follow-on   To be raised: Up to $4.6 million   Shares: 869,566   Price prior: $0.42  ...
07:00 , Oct 26, 2015 |  BC Week In Review  |  Financial News

BioRestorative Therapies amends follow-on

BioRestorative Therapies Inc. (OTCQB:BRTX), Melville, N.Y.   Business: Endocrine/Metabolic, Cardiovascular, Gene/Cell therapy   Date announced: 2015-10-16   Type: Follow-on   To be raised: Up to $11.5 million   Shares: 1.8 million   Price Prior: $0.42...
07:00 , Oct 5, 2015 |  BC Week In Review  |  Financial News

BioRestorative Therapies amends follow-on

BioRestorative Therapies Inc. (OTCQB:BRTX), Melville, N.Y.   Business: Endocrine/Metabolic, Cardiovascular, Gene/Cell therapy   Date announced: 2015-09-25   Type: Follow-on   To be raised: Up to $11.5 million   Shares: 1.6 million   Price Prior: $0.42...
07:00 , Jun 8, 2015 |  BC Week In Review  |  Financial News

BioRestorative Therapies proposes follow-on

BioRestorative Therapies Inc. (OTCQB:BRTX), Melville, N.Y.   Business: Endocrine/Metabolic, Cardiovascular, Gene/Cell therapy   Date announced: 2015-06-03   Type: Follow-on   To be raised: Up to $11.5 million   Shares: TBD   Price prior: $0.42  ...
07:00 , May 26, 2014 |  BC Week In Review  |  Company News

BioRestorative Therapies, Pfizer deal

The companies entered into a two-year research agreement to study human brown adipose tissue and cell lines. BioRestorative said it has a large collection of human brown adipose tissue samples, preadipocyte cell lines and immortalized...
07:00 , Apr 22, 2013 |  BC Week In Review  |  Financial News

BioRestorative Therapies financial update

BioRestorative implemented a 1-for-50 reverse stock split and will trade under the symbol "BRTXD," effective April 15. Following the split, the company has about 16.4 million shares outstanding. BioRestorative Therapies Inc. (OTCQB:BRTX), Jupiter, Fla.  ...
07:00 , Jun 25, 2012 |  BC Week In Review  |  Company News

BioRestorative Therapies, University of Utah deal

BioRestorative will pay the university $500,000 annually for three years to provide research services for the identification of brown fat tissue and the development and characterization of brown fat cell lines. BioRestorative, which will own...
08:00 , Feb 13, 2012 |  BC Week In Review  |  Company News

BioRestorative Therapies, Regenerative Sciences LLC deal

Regenerative will grant BioRestorative an exclusive license to use or sublicense Regenerative's stem cell injection technology and an exclusive license to use or sublicense a method for culturing cells for use in repairing damaged discs...